Article Details
Retrieved on: 2025-05-15 12:11:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... biotechnology company pioneering engineered T-regulatory (Treg) cell therapies. ... immune system. The Company is leveraging its proprietary Foxp3 ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here